Related Experiment Video
Updated: Apr 1, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in mice
Scott E Williams1, Idoia Garcia2, Andrew J Crowther3
1Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA scott_williams@med.unc.edu gershont@neurology.unc.edu.
Abstract:
Alterations in genes that regulate brain size may contribute to both microcephaly and brain tumor formation. Here, we report that Aspm, a gene that is mutated in familial microcephaly, regulates postnatal neurogenesis in the cerebellum and supports the growth of medulloblastoma, the most common malignant pediatric brain tumor. Cerebellar granule neuron progenitors (CGNPs) express Aspm when maintained in a proliferative state by sonic hedgehog (Shh) signaling, and Aspm is expressed in Shh-driven medulloblastoma in mice. Genetic deletion of Aspm reduces cerebellar growth, while paradoxically increasing the mitotic rate of CGNPs. Aspm-deficient CGNPs show impaired mitotic progression, altered patterns of division orientation and differentiation, and increased DNA damage, which causes progenitor attrition through apoptosis. Deletion of Aspm in mice with Smo-induced medulloblastoma reduces tumor growth and increases DNA damage. Co-deletion of Aspm and either of the apoptosis regulators Bax or Trp53 (also known as p53) rescues the survival of neural progenitors and reduces the growth restriction imposed by Aspm deletion. Our data show that Aspm functions to regulate mitosis and to mitigate DNA damage during CGNP cell division, causes microcephaly through progenitor apoptosis when mutated, and sustains tumor growth in medulloblastoma.
Insights
ASPM gene mutations cause microcephaly by increasing neural progenitor cell death. ASPM also drives pediatric brain tumor growth, suggesting it
Area of Science:
- Neuroscience
- Developmental Biology
- Oncology
Background:
- Gene mutations affecting brain size are linked to microcephaly and brain tumors.
- ASPM is a gene implicated in familial microcephaly.
- Medulloblastoma is the most common malignant pediatric brain tumor.
Purpose of the Study:
- To investigate the role of ASPM in cerebellar neurogenesis and medulloblastoma.
- To understand how ASPM mutations impact brain development and tumor growth.
Main Methods:
- Genetic deletion of ASPM in mouse models.
- Analysis of cerebellar granule neuron progenitors (CGNPs) and medulloblastoma.
- Assessing mitotic progression, DNA damage, and apoptosis.
Main Results:
- ASPM deletion in mice reduced cerebellar growth but paradoxically increased CGNP mitotic rate.
- ASPM deficiency led to impaired mitosis, altered cell division, and increased DNA damage in CGNPs, causing apoptosis.
- Deleting ASPM in medulloblastoma models reduced tumor growth and increased DNA damage.
Conclusions:
- ASPM regulates mitosis and mitigates DNA damage during neural progenitor cell division.
- ASPM mutations cause microcephaly via progenitor apoptosis.
- ASPM sustains medulloblastoma growth.

